Leash Bio
Founded 2021 · 13 employees on LinkedIn · 2 known investors
Find your way into Leash Bio
546 people in our graph share verified history with the Leash Bio team — schools, employers, funds. One of them is your warm intro.
Mike Zakunlockedknows Andrew Blevins · together at Cornell (overlapped)
×5knows the team · via Cornell
×4knows the team · via The University of Texas at Austin
knows the team · via Salk Institute for Biological Studies
knows the team · via Rice University
Leash Bio is a biotech company developing AI-driven drug discovery tools, combining molecular chemistry expertise with machine learning to accelerate research workflows for pharma and biotech organizations.
Founders & leadership
Leash Bio was founded in 2021 by Ian Quigley and Andrew Blevins.
IQ
Ian QuigleyinCEO, Co-founderIan Quigley is Co-founder and CEO of Leash Bio, which develops AI-driven drug discovery tools combining molecular chemistry with machine learning for pharmaceutical and biotech research.
AB
Andrew BlevinsinCTO, Co-founderCo-founder and CTO of Leash Bio, which develops machine learning tools for drug discovery.
Investors · 2
Funding
SEC filings, press & company announcements- Undisclosed amountseed fundingApr 2024Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Leash Bio do?
- Leash Bio is a biotech company developing AI-driven drug discovery tools, combining molecular chemistry expertise with machine learning to accelerate research workflows for pharma and biotech organizations.
- Who founded Leash Bio?
- Leash Bio was founded by Ian Quigley, Andrew Blevins in 2021.
- Who are Leash Bio's investors?
- Leash Bio's investors include Metaplanet, MFV Partners.